Johnson & Johnson Raises Full-Year Outlook but Misses Wall Street; Stock Declines
FROM THE WIRE · FINANCE.YAHOO.COM
Johnson & Johnson (JNJ) raised its full-year outlook on Tuesday even though the upgraded midpoints m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a…
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bearishA full-year guidance raise that misses Wall Street expectations is market-moving for a mega-cap pharma company.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Johnson & Johnson raised its full-year outlook on Tuesday.
- 02The upgraded midpoints missed Wall Street expectations.
- 03The stock declined following the announcement.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets